ATE424196T1 - Pharmazeutische zusammensetzungen mit platin- komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen - Google Patents

Pharmazeutische zusammensetzungen mit platin- komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen

Info

Publication number
ATE424196T1
ATE424196T1 AT04803751T AT04803751T ATE424196T1 AT E424196 T1 ATE424196 T1 AT E424196T1 AT 04803751 T AT04803751 T AT 04803751T AT 04803751 T AT04803751 T AT 04803751T AT E424196 T1 ATE424196 T1 AT E424196T1
Authority
AT
Austria
Prior art keywords
xanthates
pharmaceutical compositions
compositions containing
platinum complexes
therapeutic applications
Prior art date
Application number
AT04803751T
Other languages
English (en)
Inventor
Eberhard Amtmann
Wolfgang Friebolin
Gerhard Schilling
Original Assignee
Deutsches Krebsforsch
Univ Ruprecht Karls Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch, Univ Ruprecht Karls Heidelberg filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of ATE424196T1 publication Critical patent/ATE424196T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04803751T 2003-12-10 2004-12-10 Pharmazeutische zusammensetzungen mit platin- komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen ATE424196T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03028298A EP1541142A1 (de) 2003-12-10 2003-12-10 Pharmazeutische Zubereitungen enthaltend einen Platin Komplex mit einem zweiwertigen Xanthat und die therapeutische Verwendung der Zubereitungen

Publications (1)

Publication Number Publication Date
ATE424196T1 true ATE424196T1 (de) 2009-03-15

Family

ID=34486158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04803751T ATE424196T1 (de) 2003-12-10 2004-12-10 Pharmazeutische zusammensetzungen mit platin- komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen

Country Status (9)

Country Link
US (1) US20070248570A1 (de)
EP (2) EP1541142A1 (de)
AT (1) ATE424196T1 (de)
CA (1) CA2550280A1 (de)
DE (1) DE602004019818D1 (de)
DK (1) DK1708693T3 (de)
ES (1) ES2323589T3 (de)
PT (1) PT1708693E (de)
WO (1) WO2005058307A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8846712B2 (en) 2011-09-12 2014-09-30 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (de) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamidderivate als kinaseinhibitoren
WO2013167403A1 (en) 2012-05-09 2013-11-14 Sanofi Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
WO2023093837A1 (zh) * 2021-11-26 2023-06-01 湖南湘源美东医药科技有限公司 含有铂类药物或者铂类药物共晶的药物组合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE241975T1 (de) * 1998-08-25 2003-06-15 Deutsches Krebsforsch Arzneimittel enthaltend platinkomplexverbindungen sowie deren verwendung

Also Published As

Publication number Publication date
ES2323589T3 (es) 2009-07-21
EP1708693A1 (de) 2006-10-11
PT1708693E (pt) 2009-06-02
US20070248570A1 (en) 2007-10-25
DE602004019818D1 (de) 2009-04-16
WO2005058307A1 (en) 2005-06-30
EP1708693B1 (de) 2009-03-04
CA2550280A1 (en) 2005-06-30
DK1708693T3 (da) 2009-06-29
EP1541142A1 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
CY1118480T1 (el) Παραγωγα toy uk-2a
DE602004008105D1 (de) 42-o-alkoxyalkylrapamycinderivate und diese enthaltende zusammensetzungen
CY1107440T1 (el) Ενωσεις αρυλουριας εν συνδυασμω με αλλα κυτταροστατικα ή κυτταροτοξικα μεσα για τη θεραπεια ανθρωπινων καρκινων
DE60143857D1 (de) Zusammensetzung bestehend aus phy906 und chemotherapeutika
ATE461217T1 (de) Glp-1-verbindungen
BR0308113A (pt) Compostos macrocìclicos úteis como substâncias farmacêuticas
ATE408601T1 (de) Fredericamycin-derivate
AR027355A1 (es) Acidos tiazolidincarboxilicos
DE60327994D1 (de) Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften
BRPI0410503B8 (pt) composição tópica e uso da composição
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
IL184051A (en) Acetylated GLP-1 compounds, containing and using pharmaceutical preparations
ATE508114T1 (de) Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
DE69905170T2 (de) Thiazolopyrimidinderivate
DE60001974D1 (de) Derivate von flavonen, xanthonen und kumarinen
DE60003583D1 (de) Arylaminderivate und ihre verwendung als antitelomerasemittel
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
DE60216305D1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
ATE401875T1 (de) Pharmazeutische feste dispersionen von modafinil- verbindungen
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
SE9904377D0 (sv) Pharmaceutical combinations
ATE319718T1 (de) Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1708693

Country of ref document: EP

REN Ceased due to non-payment of the annual fee